It was a subtle shift. In January, in a special session on Ebola, the World Health Organization’s Executive Board called for WHO’s Director-General to provide options for a contingency fund in the context of WHO’s “need for adequate resources for [its] preparedness, surveillance and response work.” For a moment, it seemed that any additional resources that WHO […]
On November 4, many Americans will go to the polls to vote in the midterm elections. And like all election seasons, issues threatening public health are chief among this nation’s top concerns. In researching for this post, I came up with a fairly long “short-list” of pressing public health issues – […]
Posted in FDA, Health reform, National Healthcare, Uncategorized, Updates; Tagged: Antibiotic resistance, Campaign on Human Health and Industrial Farming, Eric Lander, Everytown for Gun Safety, Gun Safety, Mary Woolley, Presidential Advisory Council, Research!America.
In my last post, I discussed seven things individual consumers can do to stop the spread of antibiotic resistant superbugs. I left out one important element: the need to lobby our government’s leaders to make this issue a priority. This summer, combating antibiotic resistance is making headlines on both the national and international level. On […]
The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant. Here is a hypothetical illustration. Mr. X. has a sore throat. He buys some […]
On December 11, 2013, the Food Drug Administration (FDA) issued guidelines aimed at phasing out the use of antibiotics that are critical to human health in food-producing animals, including penicillin, azithromycin and tetracycline. Aside from treating infections in animals, livestock producers have been using antibiotics to induce growth in an animal and maximize feed. The […]
Posted in FDA; Tagged: animal, Animal Health Institute, Antibiotic resistance, Antibiotics, Bayer, Center for Veterinary Medicine, drug, drug companies, drug resistance, drugs, Elanco, infectious diseases, Johns Hopkins, Johns Hopkins Center for a Livable Future, Merck, Novartis, Pharmaceuticals, public health, Sanofi, Zoetis.
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.